Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Website: jnj.com


  • Pretty weak financial results growth rate 8.9% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (11.9%)
  • Dividend yield for the last twelve months 2.9%
  • Free cash flow yield -2.9% (LTM)
  • Share price is 25.2% higher than minimum and 1.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (14.4x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: JNJ
Share price, USD:  (-0.1%)177.88
year average price 157.93  


year start price 164.99 2024-09-05

min close price 142.06 2025-01-10

max close price 179.29 2025-08-22

current price 178.00 2025-09-04
Common stocks: 2 631 399 832

Dividend Yield:  2.9%
FCF Yield LTM: -2.9%
EV / LTM EBITDA: 14.4x
EV / EBITDA annualized: 14.8x
Last revenue growth (y/y):  +5.8%
Last growth of EBITDA (y/y):  +12.0%
Historical revenue growth:  +0.6%
Historical growth of EBITDA:  +23.3%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 468 073
Net Debt ($m): 31 881
EV (Enterprise Value): 499 954
EBITDA LTM ($m): 34 804
EV / LTM EBITDA: 14.4x
Price to Book: 6.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-09-03seekingalpha.com

Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

2025-08-31fool.com

These 4 Dividend Stocks Are Money-Printing Machines

2025-08-31prnewswire.com

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

2025-08-29zacks.com

J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure

2025-08-25zacks.com

J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?

2025-08-25fool.com

Got $500? 3 Dividend Stocks to Buy and Hold Forever

2025-08-24fool.com

2 Dividend Stocks Worth Doubling Down on Right Now

2025-08-22nypost.com

Johnson & Johnson to invest $2B in North Carolina plant as Trump's 250% drug tariffs loom

2025-08-22zacks.com

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

2025-08-21fastcompany.com

Johnson & Johnson announces $2 billion investment to boost U.S. manufacturing as tariffs loom
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data